(RTTNews) - Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc.
(MLNM) said Tuesday the Federal Trade Commission or FTC has granted early termination of the waiting period under the Hart- Scott-Rodino Antitrust Improvements Act, in connection with both the companies' merger.
On April 28, 2008, Takeda received antitrust clearance from the Austrian Federal Competition Authority, and on April 18, 2008, the German Federal Cartel Office granted Takeda's request for early clearance to proceed with the acquisition of Millennium shares under the merger agreement.
The companies noted that all of the conditions in the merger that relate to the expiration or termination of applicable anti-trust waiting periods or obtaining clearances under applicable anti-trust laws have been met.
For comments and feedback: contact editorial@rttnews.com